The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A model comparing the value of broad next-gen sequencing (NGS)-based testing to single gene testing (SGT) in patients with nonsquamous non-small cell lung cancer (NSCLC) in the United States.
 
Nathan A. Pennell
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Cota Healthcare; Genentech; Inivata; Lilly; Merck; Regeneron
Research Funding - Altor BioScience (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Jounce Therapeutics (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst)
 
Jie Zhou
No Relationships to Disclose
 
Brian Hobbs
Stock and Other Ownership Interests - Presagia
Consulting or Advisory Role - Simulstat
Research Funding - Amgen
(OPTIONAL) Uncompensated Relationships - Presagia